Device
CardioFlux Magnetocardiography
CardioFlux Magnetocardiography is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Trials by Status
completed375%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
recruiting
A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.
NCT05868902
completed
MCG for Suspected INOCA Confirmed by Thermodilution-Derived CFR
NCT06139094
completed
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
NCT03968809
completed
Women's Assessed Cardiovascular Evaluation With MCG
NCT04739280
Clinical Trials (4)
Showing 4 of 4 trials
NCT05868902
A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.
NCT06139094
MCG for Suspected INOCA Confirmed by Thermodilution-Derived CFR
NCT03968809
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
NCT04739280
Women's Assessed Cardiovascular Evaluation With MCG
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4